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The most objective indicator of asthma severity in the
clinic is the measurement of reversible airway obstruction
by spirometry. We evaluated the effect of antigen chal-
lenge on FEV100, FVC and PEF and airway cell infiltrate,
cytokine levels and lung histopathology in the Brown
Norway rat allergic model. Rats were sensitised to the
antigen ovalbumin and challenged by aerosolised oval-
bumin fourteen days later. Twenty four hours after chall-
enge the rats were terminally anaesthetised and a forced
manoeuvres procedure performed. Recruitment of
inflammatory cells and biomarker production was
assessed in bronchoalveolar lavage fluid (BALF). Antigen
challenge caused a significant (P<0.001) 30.2±2.6, 20.5
±1.7 and 43.0±3.2% reduction in FEV100, PEF and FVC.
Exposure to antigen also resulted in the significant
recruitment of eosinophils (2.13±0.60x106cells/animal),
neutrophils (2.64±36x106cells/animal) and lymphocytes
(0.53±0.05x106cells/animal) into the airway. The Th2 cyto-
kines; IL-13 and IL-5 and macrophage derived TNF-a
in addition to IL-6 and MIP-1a levels were significantly
elevated in the BALF. Oral treatment with a glucocorticoid
steroid budesonide (3 mg/kg) twice daily completely
reversed the decline in FEV100, PEF and FVC and signifi-
cantly (P<0.001) reduced the inflammatory cell infiltrate,
cytokine secretion and reduced the percentage incidences
and severity of granulomatous inflammation. We have
demonstrated that allergen challenge results in a reversible
decline in measured FEV100, PEV and FVC in a rat allergic
model. This functional measurement may be a valuable
tool for translating the efficacy of novel compounds from
rodents to the clinic.
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